MCA GAINS IN NEW DRUG ASSESSMENT SPEED DO NOT LEAD TO FASTER U.K. APPROVALS; INTRA-EUROPEAN REVIEW COMPETITION COULD COMPROMISE QUALITY, RESEARCHERS WARN
Executive Summary
The Medicines Control Agency in Britain has more than doubled the speed of its initial assessments of new active drug substances over the last eight years.